This study was conducted to highlight the significant environmental factors that may have impacts on breast benign and malignant diseases. This study was carried out on one hundred females who came to radiology department to perform mammographic examination. A complete personal and family history of patients was taken, clinical examination was done, all cases were asked to fill a questionnaire about how often they deal with each item of the environmental factors including (alcohol, caffeine, smoking, use of some material that are commonly used in daily life and known to have estrogenic effect including (food and soda cans, plastic containers, insecticides, detergents and cleaning agent, deodorants and cosmetics) then digital mammographic examination was done for all cases. Cases with high 17b Estradiol hormone blood level were excluded from the study. The quantitative data were presented as mean and standard deviations. Also qualitative variables were presented as number and percentages. The comparison between groups regarding qualitative data was done by using Chi-square test while the comparison between more than two groups with quantitative data were done by using One Way ANOVA. The confidence interval was set to 95% and the margin of error accepted was set to 5%. So, the p-value was considered significant at the level of < 0.
INTRODUCTION
Breast disease in women encompasses a spectrum of benign and malignant disorders (Morrow, 2000) . Benign breast disease (BBD) has a high prevalence and a noticeable impact on women's quality of life (Friedenreich et al., 2000) . In less-developed countries, breast cancer is the leading cause of cancer death in women; in developed countries, however, it has been surpassed by lung cancer as a cause of cancer death in women. In United States, breast cancer accounts for 29% of all cancers in women and is second only to lung cancer as a cause of cancer deaths. Several risk factors have been found to be clinically useful for assessing a patient's risk of breast cancer.
Many of these factors form the basis of breast cancer risk assessment tools currently being used in the practice (Chalasani, 2017) .
There are several breast imaging modalities available such as Ultrasound, CT, Digital Mammography, MRI and scintimammography. Mammograms are X-ray images of the breast. The images can be captured on film or stored directly onto a computer (digital). The aim of mammography is to obtain an optimum image along with maximum breast tissue visualization (Popli et al., 2014) .
A potential risk factor for breast cancer is exposure to environmental estrogens, a group of synthetic substances found in the environment that, when absorbed into a person's system, function in a similar way to estrogen.
Estrogen stimulates breast cell growth, and exposure to estrogen over long periods of time, without any breaks, can increase the risk of breast cancer (Kane, 2013) . Environmental estrogens are connected to everything from PMS (Premenstrual Syndrome) to cancer and reproductive problems in animals. In fact, environmental estrogens have been found to change our genes and give our bodies the instructions to produce cancer (Evans, 2009 ).
The present study was designed as a cross-sectional study in 2015 and 2016 to detect the association of exposure to some environmental factors (with more concern to those related to environmental estrogens) with different breast pathologies especially malignant breast diseases, aiming to reduce risk of breast cancer as much as possible.
SUBJECTS AND METHODS
The present study was designed as a cross-sectional study. It was conducted from March 2015 to July 2016 on one hundred females who came to radiology department to perform mammographic examination; this was done in Central Hospital Egypt (Nasr City next to City stars).
A standardized epidemiological questionnaire including age, smoking status, alcohol use, and family history of cancer was used to collect personal data through in-person interviews.
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Inclusion criteria are:
 Patient of known breast disease who came for follow up.
 Patients who came for regular check up.
 Patient who discovered breast abnormality during self-examination or medical assessment.
Exclusion criteria are:
 Taking any hormonal treatment.
 Having any endocrinal disease.  Having high blood estrogen level.
 Lactating women.
 Lesions due to trauma.
 Females less than 40 years old.
A complete personal and family history of patients was taken. Clinical examination was done including inspection and palpation. All cases were asked to fill a questionnaire about how often they deal with each item as follows: Never (meaning that the patient never uses this item), occasionally (meaning that the patient uses this item once or twice per week) or daily (meaning that the patient uses this item every day). Items included in the questionnaire were alcohol, caffeine, smoking, use of some material that are commonly used in daily life and known to have estrogenic effect including (food and soda cans, plastic containers, insecticides, detergents and cleaning agent, deodorants and cosmetics).
Digital mammographic examination:
Mammography was done for all cases as follows: One breast at a time was rested on a flat surface that contains the X-ray plate. A compressor was pressed firmly against the breast to help flatten out the breast tissue. The X-ray picture was taken while patient is holding her breath. Routine views were obtained: (Cranio-caudal view -top to bottom-and Medio-lateral oblique) view.
Laboratory examination: Blood samples were collected for testing 17b
Estradiol hormone at the follicular phase of the menstrual cycle. Cases with high 17b Estradiol hormone blood level were excluded from the study. Chi-square test while the comparison between more than two groups with quantitative data were done by using One Way ANOVA. The confidence interval was set to 95% and the margin of error accepted was set to 5%. So, the p-value was considered significant at the level of < 0.05. 
RESULTS
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DISCUSSION
Results of the present study showed highly significant association between age of the patient, BMI of the patient and previous mammographic examinations with occurrence of benign and malignant lesions, axillary lymphadenopathy and breast calcifications. These findings are close to that mentioned by Chalasani (2017) who stated that increasing age is an established risk factor for breast cancer.
Our results were matching with the results obtained by Goehring and Morabia (1997) and Friedenreich et al., (2000) who stated that obesity has been identified as one of the only consistent risk factors for BBD.
Our results are not matching with the results obtained by other investigators as Hislop et al., (1990) , Soini et al., (1981) , Brinton et al., (1981) , Bianchi et al., (1993) and Cole et al., (1978) Considering relation between alcohol intake and breast diseases, our study showed a significant association between alcohol intake and breast calcifications. There was no significant correlation between alcohol intake and axillary lymphadenopathy and occurrence of benign lesions and occurrence of malignant lesions. These results contradict with the results of many other investigators as Chalasani (2017) who mentioned that increased risk of postmenopausal breast cancer has been consistently associated with regular, moderate consumption of alcohol (3-5 alcoholic beverages per week). Coutelle et al., (2004) and Fan et al., (2000) and Fucic et al., (2012) mentioned that Alcohol is related with increased risk of breast cancer development as even low alcohol consumption increases serum estradiol. In a study made on animal model, alcohol increases estradiol levels in dams, which leads to higher levels of ER alpha receptors in their offspring mammary gland and may launch tumori genesis (Hilakivi et al., 2004) .
Our results were similar to those mentioned by Rohan & Cook (1989) and Friedenreich et al., (2000) who found no association between alcohol consumption and BPBD, even after stratification by degree of atypia.
Results of our study showed significant association between caffeine intake and enlarged axillary lymph nodes. No association found between caffeine intake and breast calcifications and occurrence of benign and malignant lesions. Our findings are close to those obtained by Rohan et al. (1989) and Boyle et al. (1984) who found no strong or consistent association between caffeine consumption and the potential deleterious effect on BPBD.
Moreover, Webb et al. (2004) stated that caffeine restriction may improve symptoms of BBD. Morrow (2000) mentioned that caffeine avoidance has been a popular treatment measure in women with breast pain. Unfortunately, two randomized clinical trials by Ernster et al. (1982) and Allen & Froberg (1987) failed to demonstrate a therapeutic benefit for caffeine restriction. Friedenreich et al. (2000) mentioned that no clear associations with BPBD were observed for some factors as caffeine intake.
Our results showed a high significant association between smoking and enlarged axillary lymph nodes and breast calcifications. Meanwhile, no El Sobky, Abeer et al. Vol. 43, No. 1, Sept. 2018 42 significant association was found between smoking and occurrence of benign and malignant lesions. This was similar to previous studies by Yu et al. (1992) and Berkowitz et al. (1985) who have shown no substantial effect of ever, former or current smoking; however one study by Pastides et al. (1987) found decreased risks and another study by Nomura et al. (1977) showed increased risks for BPBD associated with smoking. In this study, cigarette smoking as assessed as current, past, or passive smoking was not associated with an increased risk of BPBD. Friedenreich et al. (2000) mentioned that no clear associations with BPBD were observed for some factors as smoking.
Our study showed significant association between use of diet and soda cans, use of detergents and cleaning agents, use of insecticides, use of deodorants and use of cosmetics and occurrence of benign and malignant lesions, axillary lymphadenopathy and breast calcifications. Significant association was found between use of plastic containers and occurrence of benign and malignant lesions.
This was matching with Andersen et al. (2006) and Calafat et al. (2008) who stated that BPA is commonly found in polycarbonate plastic products including baby bottles, water bottles, food containers, in the linings of metal food cans and in dental sealants and composites. BPA has been found in over 90 % of the U.S. population age six and over, with highest concentrations in children ages 6-11.
Our results was similar to results published by Lankester et al. (2013) , who mentioned that Triclosan is commonly found in antibacterial hand soaps, toothpastes and household cleaning supplies. Phthalate chemicals "soften" plastics to make them pliable. They are also found in personal care products, food, plastic toys and household dust. Parabens are found in common personal care products including cosmetics and antiperspirants.
These results agreed with those obtained by Brody & Rudel (2003) and Brody et al. (2007) who mentioned that currently there are some 160 xenoestrogens that may be involved in breast cancer development. Women are the largest consumers of cosmetic products which may be a significant source of xenoestrogens. Some, such as metalloestrogens (e.g., aluminium salts), parabens, cyclosiloxanes, triclosan, UV screeners, phthalates, Aloe Vera extracts, and musk are present in numerous cosmetics products.
Also Rosenthal et al. (2004) mentioned that humans are exposed to these chemicals transcutaneously and measurable levels have been detected in human breast tissue.
Exposure to environmental estrogens was described by Andersen et al. (2006) who mentioned that Chemicals like polycyclic aromatic hydrocarbons (PAH), pesticides, polychlorinated biphenyl (PCB), dichlorodiphenyltrichlorethane (DDT), some drugs (e.g. antiepileptic drugs), fungicides, cotinine, phytoestrogens, mycotoxins, bisphenol A (a plastics additive), phthalates, alkylphenols, and metalloestrogens mimic estrogen action, affect estrogen levels, or bind to estrogen receptors. Fucic et al. (2012) 
